Technology Catalysts International (TCI) was founded in 1979 to provide consulting services that satisfy the technology transfer and business research needs of industry. We specialize in technology licensing, technology assessment, and technology portfolio management. The TCI headquarters are located in Falls Church, Virginia; a suburb of Washington, DC. Our global network also includes offices and associates in Argentina, the Czech Republic, Germany, India, Japan and Korea.
Our research staff is comprised of professionals with backgrounds in a variety of technical disciplines, with additional expertise in international marketing, licensing, finance, and business development.Read more
For over two decades, Technology Catalysts International has conducted specialized consulting for pharmaceutical companies.
Today's consumer is more demanding than in the past, requiring the highest quality products at reasonable cost.
The importance of biotechnology in today's industrialized economy cannot be understated.
Biomedical devices are one of the most prominent examples of technology advancement in the 21st century.
In November 2017, the FDA approved a therapeutic pill that is integrated with an ingestible sensor that can capture information about patient compliance. That product, Otsuka’s Abilify MyCite®, is indicated for schizophrenia and bipolar disorder. When the patient ingests this pill, data is sent to a patch worn on the patient’s torso. From there, the data is wirelessly transmitted to a mobile app that can be accessed by both the patient and their physician. The MyCite approval will raise awareness of this field of technology. As many as 150 firms around the world are developing digital therapeutics, according to the Economist. It is the hope that Ability MyCite, and future therapeutics like it, will be another step to increased patient compliance.See More News
May 24, 2018 - May 25, 2018 @ 8:00 am - 5:00 pm - Over 300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organizations and leading biotechnology companies Over 50 presentations and case studies focusing on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies 6 interactive streams: Discovery of Immuno-Oncology Therapies Translational Immuno-Oncology Genomics in Cancer Immunotherapy [...]See More Events
Chemspec Europe 2018, the 33rd International Exhibition for Fine and Specialty Chemicals
June 20, 2018 - June 21, 2018 @ 9:30 am - 2:45 pm - Chemspec Europe 2018, the 33rd International Exh
CPhI Worldwide 2018
October 09, 2018 - October 11, 2018 @ 8:00 am - 6:00 pm - The world’s leading pharmaceutical platf
Fabric and Home Care World Conference
October 28, 2018 - October 31, 2018 @ 5:00 pm - 12:30 pm - The inaugural Fabric and Home Care World